Catalent Consultant Day: How to Effectively Work with a Development Partner

Actions Panel

Registrations are closed

Thank you for your registration!

Catalent Consultant Day: How to Effectively Work with a Development Partner

Join us on January 8, 2020 as pharma consultants will have the opportunity to network and share challenges on early drug development.

By Catalent

Date and time

Wednesday, January 8, 2020 · 1 - 5pm PST

Location

Catalent Pharma Solutions - San Diego Site

7330 Carroll Road San Diego, CA 92121

About this event

Date: Wednesday, January 8, 2020

Time: 1:00 -5:00 PM PST

Location: On Site presentations and Catalent Site Tour

7330 Carroll Rd, San Diego, CA 92121

Networking Reception to Follow:

Ballast Point Brewing Company | 5:00-7:00 PM PST

9045 Carroll Way, San Diego, CA 92121

Designed for consultants, hear from experienced industry colleagues on the latest tips that will help your clients avoid critical pitfalls in early development of their drugs to best leverage CDMO experts to help manage and mitigate risks for your clients’ programs. Learn best in class practices from early drug development experts, as well as get insider information on how to access top experts and capabilities from the leading development and delivery technology partner that progresses hundreds of molecules thru development and launch every year.

Take a tour of Catalent’s San Diego facility that focuses on early development and the home of our Pharmatek® SD Spray Drying technologies with downstream roller compaction capabilities to support the needs of our client’s most challenging compounds. Then following the session, you are invited to our networking reception at Ballast Point Brewing Company in Miramar.

This complimentary event is designed to promote networking and you will have a chance to discuss your challenges with experts in Catalent’s Science and Technology team.

Expert Presentations

Prepare Your Clients for Success: Tips and Strategies to Avoid Dangerous Pitfalls in Consulting

Determining a client’s primary goal is critical to guiding them through the development of their asset. Additionally, their primary focus will impact the strategy used to develop the asset. This presentation will also discuss approaches we can take to ensure the best success for our clients.

Alan F. Parr, Pharm.D., Ph.D., Managing Member, BioCeutics, LLC

Integrating the Business, Regulatory and Scientific Needs of a Client

Drug development requires integrating multi-disciplinary scientific, business and regulatory activities. To successfully support a client’s program, it is important to provide advice and services that support all three in the context of a program’s goal. A key deliverable is to provide a strong risk management structure so all decisions are made with the best information possible.

Jim Spavins, Principal , SPAVINS CONSULTING LLC

Using DCS And PBPK Modeling Tools To Select The Right Formulation Strategy When Transitioning Small Molecules From Discovery To The Clinic

Get your drug through early phase development faster. Hear case studies presented in characterization and formulation of oral small molecule drugs that can help your clients succeed.

Lisa Caralli, Director of Science and Technology, Pharmaceutics, Catalent Pharma Solutions

Join us for a Networking Reception at Ballast Point Brewing Company

Following the presentations and site tour, join us for continued networking at Ballast Point Brewing Company at the Miramar location. Enjoy great beers and appetizers while continuing the conversations with our experts.

Organized by

Catalent is a global leader in drug formulation development that offers comprehensive early-phase drug development solutions.  Specializing in PBPK modeling, molecule characterization, bioavailability enhancement, API-sparing development techniques, and phase-appropriate dose forms, Catalent helps get optimal drug candidate to clinic, faster. Catalent’s integrated solutions, such as OptiForm® Solution Suite, Xpress Pharmaceutics™ and OneXpress®, aid in accelerating molecules from candidate to clinic and beyond.  Its capabilities in spray drying, lipid-based drug delivery systems, hot melt extrusion, modified-release, particle-size reduction and roller compaction, combined with broad expertise in developing challenging compounds, provide customers with optimal dosage forms to suit each project.

Sales Ended